Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial

Update your browser to view ScienceDirect.

Request details:

Request ID: 8dfb9067fb7417da-LAX
IP: 116.62.10.13
UTC time: 2024-11-09T05:57:13+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4